Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
Recruiting · NCT03642028 · Registry updated 2025-07-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress | Dyssomnias, Sleep Disorders, Intrinsic, Stress Disorders, Traumatic, acute stress disorder, insomnia, nervous system disorder, post-traumatic stress disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Phase 4 | 2025-07-18 | NCT03642028 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| VA Office of Research and Development | 472 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ralph H. Johnson VA Medical Center, Charleston, SC | Charleston | United States | 25 |
| Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC | Salisbury | United States | 8 |
| San Francisco VA Medical Center, San Francisco, CA | San Francisco | United States | 19 |
| VA Long Beach Healthcare System, Long Beach, CA | Long Beach | United States | 22 |